This is a regulatory disclosure submitted to the National Stock Exchange of India Limited and BSE Limited regarding the rescheduling of a board meeting.
The company intimates that its Board of Directors meeting, previously scheduled for November 5, 2026, has been rescheduled to November 14, 2026 (Saturday). The purpose of the meeting is to approve the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026. The reason for the rescheduling is cited as "unavoidable circumstances."
In accordance with the company's Insider Trading Code under SEBI (Prohibition of Insider Trading) Regulations 2015, the Trading Window for dealing in the securities of the company remains closed for Designated Persons and their immediate relatives. The closure will continue until 48 hours after the financial results are made public.
The disclosure is made pursuant to applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and other applicable laws. The letter is digitally signed by Dr. Dinesh S. Patel, Chairman of Themis Medicare Limited, on November 2, 2026, at 12:54:30 IST.